Caspase 8 gene expression highly reduced in atherosclerotic model cells: effect of oxidized low-density lipoprotein Authors: Burcu Bayyurt, Lutfi Bayyurt Published: 2026 ABSTRACT Background and AimApoptosis is one of the programmed cell death pathways. Cysteine protease, Caspase 8 (CASP8), starts apoptosis signaling through the extrinsic apoptotic pathway. Oxidatively modified low-density lipoprotein (ox-LDL) activates the apoptosis in vascular endothelial cells (VECs). Ox-LDL is a crucial risk factor that ultimately promoted development of atherosclerosis (AS). We purposed to investigated gene expression of CASP8 in human umbilical vein endothelial cells (HUVECs) after ox-LDL dose-dependent stimulation.MethodsWe examined CASP8 gene expression level in treated two different dose ox-LDL treated HUVECs and HUVECs without ox-LDL in current research. We made measurement with dye of Symmetrical Cyanine Benzothiazole Green (SYBR Green) utilizing the quantitative real-time polymerase chain reaction (qPCR) method.ResultsWhen we compared to HUVECs without treatment of ox-LDL, expression of CASP8 was statistically significant down-regulated (P < 0.05) in HUVECs stimulated with ox-LDL. In addition, we supported our gene expression results with permutation analysis of variance (ANOVA).ConclusionOx-LDL may affect expression of CASP8 therefore apoptosis signaling pathway in VECs. Excessive down-regulation in gene expression of CASP8 in HUVECs stimulated by ox-LDL may show potential role of it in the endothelial cell (EC) apoptosis for AS. Introduction Apoptosis is a common cell death form and an effective process in many pathological conditions including cardiovascular diseases (CVDs). Apoptosis plays an important role in the development of CVDs, particularly in atherosclerosis (AS). Endothelial cell apoptosis is considered an early event in AS and contributes to endothelial dysfunction and plaque development. Increased apoptosis of vascular cells may impair endothelial integrity and promote atherosclerotic progression. Therefore, dysregulation of apoptotic pathways is closely associated with the pathogenesis of CVDs (Ni et al., 2024; Kanavos & Birbas, 2025; Wang et al., 2026a; Wang et al., 2026b). The apoptosis initiation and regulation is highly controlled by a proteolytic enzymes family, the caspases. As initiator caspase, Caspase 8 (CASP8), is involved in the extrinsic apoptosis pathway for answering to death receptors ligations (Zhong et al., 2020). External stimuli binds to diverse death receptors of cell transmembrane and activates extrinsic apoptotic pathway. After receptor activation, various intracellular proteins influence each other to lead a signaling complex of death-inducing. The complexes prompt downstream initiator caspases, such as CASP8. CASP8 can activate intrinsic apoptotic pathway via stimulating mitochondrial stress, or can induce downstream effector caspases, which directly initiate cell components degradation and facilitate death of cell. When progressing during the apoptosis phases, CASP8 interacts with many apoptotic proteins in intracellular chemical signaling pathway (Goldblatt, Cirka & Billiar, 2021). Vascular endothelial cells plays critical role in sustaining homeostasis. Endothelial cells are active metabolic biological tissue components that has numerous crucial physiological functions (Lawal, Davids & Marnewick, 2016). It is commonly accepted that injury of endothelial cell (EC) acts as important player in diverse human diseases such as AS (Kang et al., 2021). Endothelial cell injury is considered to be an early in development of AS for CVDs (Monteiro et al., 2019). Atherosclerosis is the main chronic inflammatorydisease which is the primary cause of CVDs (Gao et al., 2022). It is characterized by artery intima thickening (Zhao et al., 2022) and associated with lipid metabolism disorders owing to possibly underlying inflammation (Wang et al., 2023). Atherosclerosis pathogenesis is unclear. LDL is oxidized in arterial wall subendothelial space for becoming ox-LDL that causes vascular endothelial injury. Oxidatively modified low-density lipoprotein (ox-LDL) further exacerbates the AS (Guo et al., 2022). Apoptosis plays a critical role in endothelial dysfunction and the development of CVDs. EC injury is a key event in the initation of the AS and ox-LDL is one of the major factors that induce endothelial dysfunction and cell death (Tian et al., 2026). Caspases, a family of cysteine-dependent aspartate proteases, play a central role in the regulation of apoptosis in CVDs, and multiple atherosclerotic risk factors are known to induce apoptotic pathways (Gundapaneni et al., 2017). CASP8 is a key regulator of cell death pathways, including apoptosis, necroptosis, and inflammation, and therefore plays an important role in vascular pathology (Zhang et al., 2024). Previous studies have demonstrated that altered expression of CASP8 is associated with CVDs and may be involved in disease progression (Zhang et al., 2024; Pavić et al., 2024). Gene expression analyses in cardiovascular patient cohorts have shown significant alterations in CASP8 expression, suggesting that dysregulation of apoptotic pathways contributes to cardiovascular pathology (Pavić et al., 2024). Ox-LDL induces apoptosis in VECs (Li & Mehta, 2000; Chen et al., 2004) and vascular smooth muscle cells (Nishio, Arimura & Watanabe, 1996). It has shown that caspase-8 play roles in the ox-LDL-induced apoptotic signaling pathway (Chen et al., 2004) in human coronary artery endothelial cells. Although ox-LDL-induced endothelial apoptosis has been widely reported, the direct effect of ox-LDL on CASP8 gene expression in ECs has not been clearly elucidated. Therefore, in this study, we purposed to investigate the effect of ox-LDL on CASP8 gene expression in human umbilical vein endothelial cells (HUVECs). Investigating the effect of ox-LDL on CASP8 gene expression may provide important insights into the molecular mechanisms of endothelial injury and development of CVDs such as AS. Since CASP8 is a key regulator of apoptosis and its altered expression has been associated with CVDs, we hypothesized that ox-LDL exposure may modulate CASP8 gene expression in ECs and therefore, contribute to development of AS. Thus, we aimed to search that whether ox-LDL alter expression of CASP8 gene HUVECs. CASP8 gene expression was compared between HUVECs stimulated with ox-LDL and HUVECs without ox-LDL stimulation. Materials and Methods Human umbilical vein endothelial cells and ox-LDL treatments Human umbilical vein endothelial cells were ensured from American Type Culture Collection. HUVECs were grown in Dulbecco’s Modified Eagle Medium (DMEM, CAPRICORN (Capricorn Scientific GmbH)) supplemented with 1% penicillin-streptomycin (Capricorn Scientific GmbH) and 10% fetal bovine serum (Capricorn Scientific GmbH) at 37 °C, 5% CO2 and under 95% humidity. Every 2–3 days, the HUVECs were picked up from the culture medium using 0.25% trypsin and passaged. The cells in the logarithmic growth phase, at ∼80–90% confluence, were utilized for experiments (Liu et al., 2020). HUVECs were categorized into two groups: Experiment groups in which HUVECs were grown in supplemented DMEM with 25 (Group 1) and 40 µg/ml ox-LDL concentration (Group 2) (Invitrogen LOT2160046, L34357 (Thermo Fisher Scientific, Waltham, MA, USA)) for 24 h (Gong et al., 2019). The other group is control group in which HUVECs were grown in supplemented DMEM without ox-LDL. Two different ox-LDL concentrations (25 µg/mL and 40 µg/mL) were used to evaluate whether ox-LDL has a dose-dependent effect on CASP8 gene expression in ECs. These concentrations were selected based on previous studies in the literature in which similar ox-LDL concentrations were used to induce endothelial dysfunction and cell injury without causing excessive cell death (Zhang & Jiang, 2016; Gong et al., 2019; Ma et al., 2024). Ox-LDL concentration level at which cell viability began to be affected was 25 µg/ml (Ma et al., 2024). Cell density decreased significantly after the application of 40 µg/ml ox-LDL in HUVECs and experiments were carried out with these two ox-LDL concentrations. Same consumables were used across all experimental conditions. In addition, freshly thawed cells were used in experiments. Gene expression RNeasy Mini Kit (Qiagen, Hilden, Germany) (QIAGEN, catalog no: 74104) was provided to extracted total RNA from the HUVECs. Complementary DNA was synthesized by utilized kit of reverse transcription (A.B.T.™ with RNase Inh. High Capacity, catalog no: C03-01-20) (A.B.T, Ankara, Turkey). Quantitative real-time polymerase chain reaction (qPCR) was performed using Symmetrical Cyanine Benzothiazole Green (SYBR Green) master mix (A.B.T.™ 2X qPCR SYBR-Green MasterMix kit, catalog no: Q03-02-05) (A.B.T, Ankara) on LightCycler 96 (Roche, Switzerland). We provided primers of CASP8 and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) genes as optimized assays in qPCR. Forward (forward primer serial no: 20220609/1-115, 5′GATGTTATTCCAGAGACTCCAG 3′) and reverse primer (reverse primer serial no: 20220609/1-116, 5′GGTAGGTAATCAGCAAATCCA 3′) specific to human CASP8 was used for qPCR. GAPDH (forward primer serial no: 20201207-99, 5′ACAACTTTGGTATCGTGGAAGG 3′; reverse primer serial no: 20201207-100, 5′GCCATCACGCCACAGTTTC 3′) was housekeeping (internal control) gene utilized in qPCR (Table 1). QPCR were performed in three replicates. No-template controls was included in the qPCR experiments, and melting curve analysis was performed to confirm the specificity of the qPCR products. 10.7717/peerj.21671/table-1Table 1Primer sequences used for qPCR analysis.GenePrimer sequence (5′- 3′)Product length (base pair) GAPDH Forward: ACAACTTTGGTATCGTGGAAGG101Reverse: GCCATCACGCCACAGTTTC CASP8 Forward: GATGTTATTCCAGAGACTCCAGReverse: GGTAGGTAATCAGCAAATCCA110 Notes. CASP8, Caspase 8; GAPDH, lyceraldehyde 3-phosphate dehydrogenase, CASP8 was used as the target gene and GAPDH was used as the reference gene. Primer sequences used for qPCR analysis. Notes. CASP8, Caspase 8; GAPDH, lyceraldehyde 3-phosphate dehydrogenase, CASP8 was used as the target gene and GAPDH was used as the reference gene. Statistic analysis We uploaded threshold cycle (Cq, Ct) values to “GeneGlobe Data Analysis Center” (https://geneglobe.qiagen.com/us/analyze; QIAGEN, Hilden, Germany) to analyze data of the CASP8 gene expression. Gene expression ratios (fold change (FC) calculations) were calculated according to the 2−ΔΔCT method. FC was calculated as ratio of the relative gene expression between the control and experiment groups (Group 1 and Group 2). Values higher than 1 show up-regulation (increased gene expression), while values between 0 and 1 show down-regulation (decreased gene expression). FC values equal to 1 shows no change between the groups. If a FC value greater than 1, the fold regulation (FR) and FC values are the same. For FC values less than 1, the FR is the negative inverse of the fold change value. Mann–Whitney U test was performed using delta Ct (ΔCt) values (CASP8Ct-GAPDHCt in all groups) to calculate P value. ΔCt values are normalized values. P values lower than 0.05 were accepted statistically significant (Livak & Schmittgen, 2001). In this study, because the ΔCt values for the CASP8 gene did not contain within-group variance in the ox-LDL-treated groups, estimation of the error term (within-group variance), one of the fundamental assumptions of one-way analysis of variance (ANOVA), was not achieved. Therefore, classical parametric one-way ANOVA is not statistically applicable. To reliably test group effects without adhering to parametric assumptions, a permutation-based one-way analysis of variance with 5,000 replicates was preferred for CASP8 gene. Permutation ANOVA provides a more robust and assumption-free testing approach under conditions of zero variance and small samples because it allows the evaluation of observed group differences based on the empirical distribution generated by random resampling. Effect size analyses were performed to assess the magnitude of the difference between the dose groups and the control group. Because repeated measurements at the 25 and 40 µg/ml ox-LDL doses did not reveal any variance, the classical Cohen’s d coefficient could not be calculated; instead, the Glass Δ effect size, based on the standard deviation of the control group, was used. High Glass Δ values were interpreted to indicate the magnitude of the biological effect of the ox-LDL dose on CASP8 gene expression. All analyses were conducted in Python (v3.12) using the SciPy and NumPy packages. External transcriptomic validation using the GSE137578 dataset The public transcriptomic dataset GSE137578 from the Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE:GSE137578) was used to externally validate our qPCR findings. This dataset contains gene expression profiles of human aortic endothelial cells (HAECs) exposed to ox-LDL and untreated control cells. Differential expression analysis between ox-LDL-treated and control samples was performed using the limma package in R. Expression data were normalized according to the original GEO platform processing procedures, and empirical Bayes moderated t-tests were applied to identify differentially expressed genes. P-values were adjusted for multiple testing using the Benjamini–Hochberg false discovery rate (FDR) method. To specifically evaluate the consistency of the experimental findings, expression change of CASP8 was extracted from the differential expression results. The expression distribution of CASP8 was additionally visualized using boxplots displaying individual biological replicates and mean ± standard deviation values. Results We measured CASP8 gene expression level in experiment groups compared to the control group after qPCR. Ct values of gene of interest (CASP8) and housekeeping gene (GAPDH) in groups were utilized for calculating difference in gene expression. For CASP8 gene, mean of the Ct values was 26.49 and 28.34 in Group 1 and Group 2, respectively while control group’ mean of Ct was 18.73. For GAPDH gene, mean of the Ct values in Group 1, Group 2 and control groups were 28.54, 27.39 and 28.21, respectively. We compared CASP8 gene expression level between HUVEC stimulated with 25 µg/ml ox-LDL and 40 µg/ml ox-LDL (experiment groups) and HUVEC with no ox-LDL stimulation (control group). Delta Ct values representing the relative expression level of the CASP8 gene compared to the reference gene in the control and experimental groups were demonstrated in Fig. 1. An examination of the ΔCt values for the CASP8 gene clearly demonstrates that ox-LDL administration exerts a highly potent suppressive effect on gene expression, increasing with dose. In the control group, the ΔCt value was approximately −9, but in the 25 µg/ml ox-LDL group, it increased to −2. In 40 µg/ml ox-LDL group, this value was higher than 0 (Fig. 1). This significant increase demonstrated a significant decrease in CASP8 gene expression compared to the control group. The fact that ΔCt reached approximately 1 in the highest dose group, the 40 µg/ml group, indicating a relative down-regulation of CASP8 gene expression. Repeated measurements yielded identical values in the 25 and 40 µg/ml groups, in particular, supports the strong and consistent dose response. Overall, the graph clearly demonstrates a significant and dose-related down-regulation of the CASP8 gene against ox-LDL (Fig. 1). Expression of the CASP8 gene was down-regulated statistically significant in Group 1 and Group 2 when compared to control group (P = 0.03). CASP8 expression was also compared between Group 1 and Group 2. CASP8 was down-regulated statistically significant in Group 2 compared Group 1 (P < 0.001). Fold change and FR values are in Table 2. CASP8Δ Ct values in control and ox-LDL-treated HUVECs. HUVECs were treated with 25 µg/mL (Group 1) and 40 µg/mL (Group 2) ox-LDL and compared with untreated control cells (Control). Gene expression levels were calculated using the Δ Ct method (Ct CASP8 –Ct GAPDH). Each group included three technical replicates. Statistical comparisons between groups were performed using the Mann–Whitney U test due to the small sample size. CASP8 gene expression was significantly down-regulated in both Group 1 and Group 2 compared to the control group (P = 0.03). Furthermore, CASP8 expression was significantly lower in Group 2 than in Group 1 (P < 0.001). Lower ΔCt values indicate higher gene expression. 10.7717/peerj.21671/table-2Table 2Fold change of CASP8 gene expression between groups. Gene Fold change (comparing to control) Group 1 Group 2 Fold change Fold regulationP valueFold change Fold regulationP value GAPDH 1.00Nan1.00Nan CASP8 0.01–172.840.03*0.00–1,382.760.03* Group 1 comparing to Group 2 GAPDH 1.00Nan CASP8 0.12–8.00<0.001* Notes. CASP8Caspase 8GAPDHGlyceraldehyde 3-phosphate dehydrogenaseP valueSignificant valueCtThreshold cycle *Statistic significant Group 1HUVECs were grown in supplemented DMEM with 25 µg/ml ox-LDL Group 2HUVECs were grown in supplemented DMEM with 40 µg/ml ox-LDL -sign indicates down-regulation NanNot a number indicates undefined numerical value for reference gene GAPDH, therefore does not have a fold regulation value for GAPDH. Fold change of CASP8 gene expression between groups. Notes. CASP8Caspase 8GAPDHGlyceraldehyde 3-phosphate dehydrogenaseP valueSignificant valueCtThreshold cycle *Statistic significant Group 1HUVECs were grown in supplemented DMEM with 25 µg/ml ox-LDL Group 2HUVECs were grown in supplemented DMEM with 40 µg/ml ox-LDL -sign indicates down-regulation NanNot a number Caspase 8 Glyceraldehyde 3-phosphate dehydrogenase Significant value Threshold cycle Statistic significant HUVECs were grown in supplemented DMEM with 25 µg/ml ox-LDL HUVECs were grown in supplemented DMEM with 40 µg/ml ox-LDL sign indicates down-regulation Not a number indicates undefined numerical value for reference gene GAPDH, therefore does not have a fold regulation value for GAPDH. Variance analyses performed on ΔCt values for the CASP8 gene showed statistically significant differences between the dose groups. Parametric one-way ANOVA revealed a statistically significant difference for CASP8 with F = 400.69 and p = 4.1 ×10−7. Due to the small sample size and low within-group variance, an ANOVA with 5,000 permutations yielded similar statistically significant results (p_perm = 0.0024). The same F value in both tests indicates that the observed difference is strong and consistent, and the preservation of significance in the permutation test indicates that the results are robust, regardless of distributional assumptions (Table 3). Glass Δ values indicate that both 25 µg/ml and 40 µg/ml ox-LDL doses have a highly potent suppressive effect on CASP8 gene expression. The effect size of 9.23 obtained in the comparison of control and HUVEC treated with 25 µg/ml ox-LDL indicates a significant reduction in CASP8 gene expression. The very high Glass Δ value of 12.96 in the comparison of control and HUVEC treated with 40 µg/ml ox-LDL indicates that the high dose of ox-LDL almost completely silences the CASP8 gene (Table 4). 10.7717/peerj.21671/table-3Table 3Permanova analysis results based on ΔCt for the CASP8 gene. Test type F value P-value Permütasyon ANOVA (5,000 perm.) 400.69440.0024* Notes. P-value, Significant value.*Statistic significant, ΔCt: Delta Ct, CASP8: Caspase 8. Permanova analysis results based on ΔCt for the CASP8 gene. Notes. P-value, Significant value. Statistic significant, ΔCt: Delta Ct, CASP8: Caspase 8. 10.7717/peerj.21671/table-4Table 4Effect sizes in the CASP8 gene (GlassΔ). Groups Average difference (ΔCt) SD (Control) Glass Δ Control vs 25 µg/ml 7.430.8059.23 Control vs 40 µg/ml 10.430.80512.96 Notes. ΔCtDelta Ct SDStandard deviationCASP8Caspase 8 Effect sizes in the CASP8 gene (GlassΔ). Notes. ΔCtDelta Ct SDStandard deviationCASP8Caspase 8 Delta Ct Standard deviation Caspase 8 External transcriptomic validation of CASP8 expression using the GSE137578 dataset Independent public transcriptomic dataset GSE137578 was analyzed to externally validate the qPCR findings. This dataset contains HAECs exposed to ox-LDL and untreated control cells. Differential expression analysis identified significant down-regulation of CASP8 in ox-LDL-treated ECs compared with controls (log2FC = −0.888, adjusted P = 0.0035; Table 5). The expression distribution of CASP8 across control and ox-LDL-treated HAEC samples is presented in Fig. 2. Consistent with the qPCR results obtained in the present study, CASP8 expression was reduced in the ox-LDL-treated group. This provides independent transcriptomic support for the observed down-regulation of CASP8 after ox-LDL stimulation. 10.7717/peerj.21671/table-5Table 5Differential expression results of CASP8 in the independent GSE137578 validation dataset (ox-LDL-treated HAECs versus untreated controls). Gene Probe ID log2FC P-value Adjusted P-value (FDR) Regulation CASP8 A_24_P157087−0.8880.000350.00354Down-regulated Notes. Differential expression analysis was performed using the limma package. Positive log2FC values indicate higher expression in ox-LDL-treated cells, whereas negative log2FC values indicate lower expression compared with untreated controls. Statistically significant genes after Benjamini–Hochberg correction (FDR < 0.05) were CASP8, CASP8, Caspase 8; HAECs, Human aortic endothelial cells. Differential expression results of CASP8 in the independent GSE137578 validation dataset (ox-LDL-treated HAECs versus untreated controls). Notes. Differential expression analysis was performed using the limma package. Positive log2FC values indicate higher expression in ox-LDL-treated cells, whereas negative log2FC values indicate lower expression compared with untreated controls. Statistically significant genes after Benjamini–Hochberg correction (FDR < 0.05) were CASP8, CASP8, Caspase 8; HAECs, Human aortic endothelial cells. External transcriptomic validation of CASP8 expression using the independent GSE137578 dataset. Expression levels of CASP8 in untreated control and ox-LDL-treated human aortic endothelial cells (HAECs) obtained from the independent GSE137578 dataset. Individual points represent biological replicates (n = 3 per group). Boxes indicate the interquartile range, horizontal lines represent the median, and error bars show the mean ±standard deviation. Differential expression analysis demonstrated significant down-regulation of CASP8 in ox-LDL-treated endothelial cells (ECs) compared with untreated controls (log2FC = −0.888, adjusted P = 0.0035). This expression pattern was consistent with our qPCR findings obtained in the present study. Discussion Suitable regulation of cell death is serious, since both reduced and excessive apoptotic rates can cause to initiation of CVDs. Though early AS mechanisms are still a research effective zone, it is known that the layer of VEC which lines artery wall is disrupted in the AS. The layer of endothel continuously proliferates for renewing the intimal layer of blood vessels. Vascular endothelial cells expose to the apoptosis result from overcrowding or injury (Ohsawa, Vaughen & Igaki, 2018). Caspase 8 is central factor in pathways of cell death (Kesavardhana, Malireddi & Kanneganti, 2020; Orning & Lien, 2021). It was implicated that the observed activation of CASP8 was accompanied by the presence of main apoptosis hallmarks (Cristaldi et al., 2023). Dysregulation in expression levels or activity is associated with the numerous human diseases pathogenesis, such as CVDs included in AS. Studies show that caspase activity modulation can crucially ameliorate progression of the disease (Zhang et al., 2024). We focus on how ox-LDL may effect apoptosis in terms of CASP8 gene expression in the cardiovascular system and therefore contribute to progression of CVDs. Thus, we compared CASP8 gene expression of HUVECs in terms of ox-LDL exposure. Since HUVEC is among cell lines used for studying CVDs in vitro, we performed our experiment in HUVECs. In vitro models permit the study molecular and cellular mechanisms of the disease and supply a search platform to screen potential therapeutic agents. Although there are alternative models, like ex vivo models and animal models, in vitro models show higher experimental reproducibility and flexibility. In vitro models are a valuable tool to understand CVDs and thus AS pathophysiological mechanisms. Many risk agents of CVDs promote the expression of several apoptotic agents in ECs. Conclusively, activation of endothel can cause to dysfunction of the EC (Grego et al., 2025). Researches have demonstrated that injury of endothel is involved in pathogenesis of the AS, which involves the high EC apoptosis frequency in AS initial stages. Function and integrity of the endothelial is easily changed by inducing AS (Chen et al., 2004). Thus, the VEC apoptosis role in AS has attracted attention. A lot of studies have demonstrated that ECs are highly sensitive to lipid peroxidation and free radicals. Moreover, in an effort to clear the lipids, ECs change the lipid to foam cells which is major endothelial injury caused by ox-LDL (Wu et al., 2012). Oxidized-LDL can activate apoptosis in a various tissues and cells including smooth muscle cells, coronary artery ECs, and macrophages (Chen et al., 2004). Several studies have proposed that ox-LDL has a serious role in the AS pathogenesis and the atherosclerotic plaque destabilization, and acute myocardial infarction (Chen et al., 2004). Oxidized-LDL is accepted risk factor to stimulate injury of the EC for contributing to the AS process under pathological conditions (Su et al., 2018; Li, Chen & Shi, 2022; Gao et al., 2024). Wu et al. (2012) explored CASP8 protein expression involment to the pathway of ox-LDL-induced apoptosis of HUVECs (Wu et al., 2012). HUVECs stimulated with 80 mg/l ox-LDL for 24 h and CASP8 activitiy was examined using western blot analysis. It was found that 80 mg/l ox-LDL-stimulated cells demonstrated an increased rate of apoptosis. In the study by Wu et al. (2012), HUVECs treated with 80 µg/mL ox-LDL for 24 h showed that no significant increase was observed in CASP8 protein expression (Wu et al., 2012). In our study, HUVECs treated with 40 µg/mL ox-LDL showed a significant decrease in CASP8 gene expression compared to both the control group and the 25 µg/mL ox-LDL group. These findings suggest that ox-LDL may differentially regulate caspase pathways depending on concentration and experimental conditions. While Wu et al. (2012) reported activation of the intrinsic apoptotic pathway, our findings indicate that CASP8 expression may be suppressed under ox-LDL treatment, which may suggest alterations in the extrinsic apoptotic pathway. Ox-LDL induces transcriptomic and epigenomic changes in ECs (Jiang et al., 2025) and it reduces cell viability in a dose-dependent manner (Zhang & Jiang, 2016). Ox-LDL is known to has different biological effects depending on its concentration (Zhang & Jiang, 2016; Gong et al., 2019; Ma et al., 2024). Lower concentrations mainly induce endothelial dysfunction, whereas higher concentrations may induce apoptosis or other forms of cell death (He et al., 2025). In the present study, CASP8 gene expression decreased with increasing ox-LDL concentrations. CASP8 gene expression decreased in ox-LDL-treated groups compared to the control group, and the decrease was more pronounced in the 40 µg/mL ox-LDL group compared to the 25 µg/mL group. This finding suggests a dose-dependent effect of ox-LDL on CASP8 gene expression in ECs. Previous studies have reported ox-LDL concentration-dependent effects on ECs (Wang et al., 2026a; Wang et al., 2026b). Therefore, our findings are consistent with the literature and suggest that increasing ox-LDL concentration may lead to greater suppression of CASP8 expression in ECs. Previous gene expression study in patients with hypertrophic cardiomyopathy have reported dysregulation of apoptosis-related genes, including CASP8, and CASP8 down-regulation has been reported in patient cohorts (Pavić et al., 2024). CASP8 is not only an initiator of extrinsic apoptosis but also a key inhibitor (Oberst et al., 2011) and regulator of necroptosis and inflammation (Fritsch et al., 2019; Zhang et al., 2024). Therefore, decreased CASP8 expression observed in our study may suggest a shift from apoptotic cell death toward alternative cell death pathways such as necroptosis under high ox-LDL exposure. This may be associated with endothelial dysfunction and inflammatory processes rather than classical apoptosis alone. These findings may help to explain the molecular mechanisms underlying endothelial dysfunction in CVDs including AS. However, further studies including protein-level and functional assays are required to clarify the exact cell death mechanism. The significant decrease in CASP8 expression in HUVEC after ox-LDL treatment may result in apoptosis inhibition. This may accelerate the activation of an alternative cell death pathway such as necrosis and pyroptosis. It is clear that CASP8 is a crucial determinant that effect and interplay among pyroptosis, apoptosis, and necroptosis, serving as a key regulator of cellular homeostasis and cell fate. CASP8 functions as an important molecular regulator that inhibits necroptosis. When CASP8 activity is reduced, receptor interacting serine/threonine kinase 1 and 3 form a necrosome complex that activates the necroptotic pathway, leading to inflammatory cell death (Zhang et al., 2024). Therefore, decreased expression of CASP8 detected in our study may indicate suppression of apoptosis and activation of necroptosis-related pathways under ox-LDL exposure. In addition, in our previous study using the same experimental model and ox-LDL concentrations, fas ligand (FASL) gene expression was significantly higher in the 40 µg/mL ox-LDL group compared to the 25 µg/mL group (Bayyurt & Arslan, 2025). In the present study, however, CASP8 expression was more strongly down-regulated at the higher ox-LDL concentration. Since FASL is an upstream activator of the extrinsic apoptotic pathway and CASP8 is a downstream initiator caspase in this pathway (Zhang et al., 2024), these findings may indicate a dysregulation of the extrinsic apoptotic pathway under high ox-LDL conditions. The decrease in CASP8 expression despite increased FASL expression may suggest impaired apoptotic signaling or a shift toward alternative regulated cell death pathways such as necroptosis. CASP8 is known to function as a molecular switch among apoptosis, necroptosis, and pyroptosis (Fritsch et al., 2019). In this study, an independent transcriptomic validation analysis was also performed to validate a significant decrease in CASP8 expression after ox-LDL treatment, and the GSE137578 dataset was examined. This dataset also showed a significant decrease in CASP8 expression in HAECs treated with ox-LDL (Guo et al., 2024). The agreement between the qPCR results and the findings from the independent transcriptomic dataset suggests a reproducible endothelial response to ox-LDL stimulation. However, analysis of additional datasets of human atherosclerotic plaques revealed a different expression pattern. CASP8 expression was found to be increased in atherosclerotic lesions compared to non-atherosclerotic arterial tissues in the GSE43292 and GSE100927 datasets. Higher CASP8 expression was observed in advanced-stage plaques compared to early-stage plaques in the GSE28829 dataset (Meng et al., 2026). Transcriptomic studies performed on human carotid atherosclerotic tissues also show that significant changes occur in apoptosis-related pathways during inflammatory activation and plaque progression (Folkersen et al., 2012). Considering these findings together, it is understood that CASP8 expression may vary depending on the different stages of AS. This interpretation is supported by studies showing that CASP8 plays a significant role not only as an initiator of the extrinsic apoptotic pathway but also in the regulation of inflammatory signaling and immune cell activation (Boatright & Salvesen, 2003; Kearney et al., 2015). Furthermore, it is known that apoptotic and inflammatory signaling networks are closely related during atherosclerotic plaque development (Galluzzi et al., 2018). Considering all findings together, it is thought that CASP8 may assume different roles in different stages of AS. Therefore, the differential expression patterns observed in human plaque tissues using EC models can be explained by differences in disease stage, cellular composition, and the local inflammatory environment. In the present study only CASP8 gene expression was evaluated and performed in silico validation and comparisons. Further studies are planned to assess the expression and activation of key molecular markers of these pathways in order to better elucidate the underlying molecular mechanisms of different cell death. There are several limitations in the present study. First, apoptosis was evaluated only at the mRNA level through CASP8 gene expression analysis. Additional apoptosis-related markers and protein level validation experiments were not included in this study. Therefore, our results should be interpreted as evidence of apoptosis-related gene expression changes rather than direct confirmation of apoptosis. Future studies including protein-level and functional apoptosis assays are needed to confirm these findings. Other limitations of this study are inability to test ox-LDL treatments in much different amounts for different durations and limited number of cell experiment replicates because of limited ox-LDL. Another limitation of this study is the lack of functional experiments to directly assess the role of CASP8 in ox-LDL-treated ECs. Functional studies using CASP8 knockdown or overexpression (e.g., siRNA or CRISPR-Cas9 approaches) would help to clarify whether the observed changes in CASP8 expression are directly related to ox-LDL. Conclusion This paper examined impact of ox-LDL on CASP8 gene expression. As a result, we have shown that ox-LDL decreased CASP8 gene expression in HUVECs. Abnormal CASP8 gene expression may be closely associated with AS prognosis. Our findings suggest that ox-LDL may effect apoptosis-related molecular changes in ECs through CASP8-associated pathways. In conclusion, the present study showed that ox-LDL treatment resulted in dose-dependent down-regulation of CASP8 gene expression in ECs. These findings indicate that ox-LDL may influence apoptosis-related pathways at the transcriptional level. As this study was limited to gene expression analysis, and further studies including protein level and functional analyses are needed to better understand the role of CASP8 in ox-LDL-induced EC injury. Supplemental Information qPCR raw data of all groups in HUVECs Each data indicates the value of threshold cycle (Ct or Cq) in all of groups (ox-LDL treatments and controls) in qPCR qPCR raw data in 40 microgram ox-LDL treatment vs. 25 microgram ox-LDL treatment in HUVECs Each data indicates the values of threshold cycle (Ct or Cq) in 40 microgram ox-LDL treatment vs. 25 microgram ox-LDL treatment in HUVECs MIQE checklist